Reshaped human antibody to human interleukin-6 receptor
US7479543B2 · kind B2 · utility
197Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2004 |
| Grant date | Jan 20, 2009 |
| Priority date | — |
| Expiry date | Jul 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A reshaped human antibody to the human IL-6R, comprising: Since major portion of the reshaped human antibody is derived from a human antibody and the mouse CDRs which are less immunogenic, the present reshaped human antibody is less immunogenic to human, and therefor is promised for therapeutic uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.